05:02 PM EDT, 05/07/2024 (MT Newswires) -- Fady Ibraham Malik, Executive Vice President, Research & Development, on May 07, 2024, sold 15,547 shares in Cytokinetics ( CYTK ) for $1,012,265. Following the Form 4 filing with the SEC, Malik has control over a total of 137,056 shares of the company, with 137,056 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224014445/xslF345X03/form4.xml